Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001144204-16-098651
Filing Date
2016-05-03
Accepted
2016-05-03 16:51:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B4 v438656_424b4.htm 424B4 992530
2 GRAPHIC tlogonew.jpg GRAPHIC 8637
3 GRAPHIC tpg52.jpg GRAPHIC 75419
4 GRAPHIC tpg54.jpg GRAPHIC 107702
5 GRAPHIC tpg55.jpg GRAPHIC 33587
6 GRAPHIC image_002.jpg GRAPHIC 28996
  Complete submission text file 0001144204-16-098651.txt   1344472
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-209323 | Film No.: 161616127
SIC: 2834 Pharmaceutical Preparations